Identification of severe combined immunodeficiency by T-cell receptor excision circles quantification using neonatal guthrie cards.
暂无分享,去创建一个
H. Kanegane | T. Morio | Hiroki Sato | M. Yamada | T. Ariga | T. Miyawaki | K. Imai | S. Nonoyama | K. Akahane | S. Yamaguchi | J. Reichenbach | Y. Hashii | Makoto Yoshida | C. Kobayashi | M. Tsuchida | T. Taga | K. Kogawa | Y. Sasahara | Y. Kamachi | N. Nakagawa | S. Kumaki | Y. Ohtsuka | M. Endo | K. Ishigaki | H. Hisakawa | N. Kobayashi | T. Oh-ishi | Y. Okimoto | R. Miyaji | Y. Morinishi | Tomonari Urabe | Y. Tsuji | Katsuyuki Horiuchi | Y. Kaneda | Hiroki Sato | S. Yamaguchi | T. Oh‐ishi
[1] D. Babovic‐Vuksanovic,et al. High incidence of profound biotinidase deficiency detected in newborn screening blood spots in the Somalian population in Minnesota , 2009, Journal of Inherited Metabolic Disease.
[2] Edward R B McCabe,et al. Two-tiered universal newborn screening strategy for severe combined immunodeficiency. , 2005, Molecular genetics and metabolism.
[3] A. Fischer,et al. A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection. , 2005, The Journal of clinical investigation.
[4] U. Pannicke,et al. A variant of SCID with specific immune responses and predominance of γδ T cells , 2005 .
[5] E. Stiehm,et al. Potential costs and benefits of newborn screening for severe combined immunodeficiency. , 2005, The Journal of pediatrics.
[6] A. Fischer,et al. Severe combined immunodeficiency. A model disease for molecular immunology and therapy , 2005, Immunological reviews.
[7] J. Puck,et al. Development of population-based newborn screening for severe combined immunodeficiency. , 2005, The Journal of allergy and clinical immunology.
[8] R. Buckley. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. , 2004, Annual review of immunology.
[9] M. Hershfield. Genotype is an important determinant of phenotype in adenosine deaminase deficiency. , 2003, Current opinion in immunology.
[10] A. Fischer,et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99 , 2003, The Lancet.
[11] J. Puck,et al. Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. , 2002, Blood.
[12] Rob J. de Boer,et al. Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection , 2000, Nature Medicine.
[13] B. Haynes,et al. Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. , 2000, The New England journal of medicine.
[14] R. Koup,et al. Identification of a human recent thymic emigrant phenotype. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[15] J. Roberts,et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. , 1999, The New England journal of medicine.
[16] Louis J. Picker,et al. Changes in thymic function with age and during the treatment of HIV infection , 1998, Nature.
[17] J. Puck,et al. Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. , 1997, The Journal of pediatrics.
[18] S. Korsmeyer,et al. Deletion of the human T-cell receptor δ-gene by a site-specific recombination , 1988, Nature.
[19] E. Giblett,et al. Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. , 1972, Lancet.